Predictive value of FIB-4 versus fibrotest, APRI, FIBROINDEX and FORNS to noninvasively estimate fibrosis in hepatitis C

Hepatology

Volumn 47, Issue 2, 2008, Pages 763-

  Vallet Pichard, Anais ^a   Mallet, Vincent ^a   Pol, Stanislas ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE;

ACUTE TOXICITY; ALCOHOL LIVER DISEASE; AMINOTRANSFERASE BLOOD LEVEL; CHRONIC HEPATITIS; DIAGNOSTIC ACCURACY; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALARIA; PORTAL HYPERTENSION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; THROMBOCYTE COUNT; THROMBOCYTOPOIESIS;

EID: 39549107357     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22113     Document Type: Letter

References (2)

1. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. HEPATOLOGY 2006;43:1317-1325.
2. Fontaine H, Petitprez K, Roudot-Thoraval F, Trinchet JC. Guidelines for the diagnosis of uncomplicated cirrhosis. Gastroenterol Clin Biol 2007;31:504-509.